ETHealthworld.com brings latest glaxosmithkline pharmaceuticals news, views and updates from all top sources for the Indian Health industry.
Transpire Bio, an integrated clinical-stage biopharmaceutical company focused on developing inhaled therapeutics for ...
GSK has secured approval in China for Trelegy Ellipta as a maintenance treatment for adults with asthma, adding to its existing indication in COPD and making it the only single inhaler triple therapy ...
12d
Royalty Pharma to Announce Fourth Quarter and Full Year 2025 Financial Results on February 11, 2026
NEW YORK, Jan. 20, 2026 (GLOBE NEWSWIRE) -- Royalty Pharma plc (Nasdaq: RPRX) today announced that it will report its fourth quarter and full year 2025 financial results on Wednesday, February 11, ...
Detailed price information for Theravance Bio Ord (TBPH-Q) from The Globe and Mail including charting and trades.
NEW YORK, Jan. 09, 2026 (GLOBE NEWSWIRE) -- Royalty Pharma plc (Nasdaq: RPRX) today announced that its board of directors has declared a dividend for the first quarter of 2026 of $0.235 per Class A ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results